INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Development and Validation of RP-HPLC Method For Estimation of Dapagliflozin in Raw and Bulk Dosage Form
Authors Name:
Miss Khakare Kranti
, Mr. Maske Kartik , Miss Wasnik S. K , Dr. Sunil D. Kolhe , Mr. Pathade Saurabh
Unique Id:
IJSDR2304098
Published In:
Volume 8 Issue 4, April-2023
Abstract:
Dapagliflozin is used as Antidiabetic drug that works on kidney, by reabsorption of glucose in kidney by sodium glucose co-transporter.[1] Drug is used alone or in combination with drugs such as Saxagliptin, Metformin, Glimepiride. Various analytical methods are used for the estimation of API Dapagliflozin, such as RP-HPLC, UPLC and UV Spectroscopy. This review mainly focuses on the gathering information about mobile phases and other chemicals used in the separation and estimation of Dapagliflozin in single or in combination by RP-HPLC. The following study deciepts the review on analytical methods which include estimating the Antidiabetic drug.
Keywords:
Dapagliflozin, Diabetes Mellitus, RP-HPLC
Cite Article:
"Development and Validation of RP-HPLC Method For Estimation of Dapagliflozin in Raw and Bulk Dosage Form ", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 4, page no.527 - 532, April-2023, Available :http://www.ijsdr.org/papers/IJSDR2304098.pdf
Downloads:
000337070
Publication Details:
Published Paper ID: IJSDR2304098
Registration ID:205085
Published In: Volume 8 Issue 4, April-2023
DOI (Digital Object Identifier):
Page No: 527 - 532
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn